Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Hematology, Oncology Clinical Trial
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Status: Enrolling
Updated: 7/12/2012
Midwest Children's Cancer Center at Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant
Status: Enrolling
Updated: 3/23/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology Clinical Trial
Efficacy of Provex CV Supplement to Reduce Markers of Inflammatory Cytokines and Blood Pressure in Subjects With Metabolic Syndrome
Status: Enrolling
Updated: 7/29/2011
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
Status: Enrolling, Phase I, II
Updated: 12/6/2013
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Status: Enrolling
Updated: 11/21/2011
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Other Clinical Trial
Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates
Status: Enrolling
Updated: 6/2/2011
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Status: Enrolling, Phase I
Updated: 9/20/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Registry of Older Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Refractory Multiple Myeloma Clinical Trial
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 2/19/2016
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Status: Enrolling
Updated: 7/7/2010
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
Midwest Children's Cancer Center at Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
University of Denver School of Medicine Sickle Cell Treatment & Research Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Brooklyn Hospital Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Comprehensive Cancer Center of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Sickle Cell Center of S. Louisiana, Tulane University School of Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ixazomib in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Hematology, Oncology, Pharmacology / Toxicology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
University of Virginia Children's Hospital
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
University of Kansas Medical Center
mi
from
Fairway, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Riley Hospital for Children, Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Tulane University Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Status: Enrolling, Phase II
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Status: Enrolling, Phase II
Updated: 12/31/1969
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trial
Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy
Status: Enrolling, Phase I
Updated: 10/18/2013
Northwestern Memorial Hospital SC
mi
from
Chicago, IL
Click here to add this to my saved trials
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trial
Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy
Status: Enrolling, Phase I
Updated: 10/18/2013
Duke University Medical Center SC-5
mi
from
Durham, NC
Click here to add this to my saved trials
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trial
Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy
Status: Enrolling, Phase I
Updated: 10/18/2013
Oregon Health & Science University Dept. Hematologic Malignancies
mi
from
Portland, OR
Click here to add this to my saved trials
Acute Myeloblastic Leukemia Clinical Trial
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Status: Enrolling, Phase II
Updated: 7/18/2013
Vanderbuilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Acute Myeloblastic Leukemia Clinical Trial
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Status: Enrolling, Phase II
Updated: 7/18/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 10/16/2017
John Theurer Cancer Center At Hackensack UMC
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 10/16/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 10/16/2017
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 10/16/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 10/16/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 2/3/2013
Hospital for Special Surgery
mi
from
New York City, NY
Click here to add this to my saved trials
Leukemia Clinical Trial
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling, Phase II
Updated: 2/27/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Atypical Hemolytic-Uremic Syndrome Clinical Trial
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Psychiatry / Psychology, Other, Reproductive Clinical Trial
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Presbyterian - Saint Lukes Medical Center - Health One
mi
from
Denver, CO
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of Transfusion of Older Red Blood Cells on Patients With Hemoglobinopathies
Status: Enrolling
Updated: 2/16/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Tandem Auto Transplantation in Myeloma Patients With
Status: Enrolling
Updated: 6/6/2012
University of Iowa - Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
Status: Enrolling, Phase II
Updated: 3/28/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Blood and Marrow Transplant (BMT) Clinical Trial
Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation
Status: Enrolling, Phase
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Thermal Burns Clinical Trial
Chronology of Occult and Gross Coagulopathy in Burn Patients
Status: Enrolling
Updated: 7/13/2016
MedStar Washington Hospital Center
mi
from
Washington DC,
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
National Cancer Institute Developmental Therapeutics Clinic
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
City of Hope South Pasadena
mi
from
South Pasadena, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Autophagy Induction After Bortezomib for Myeloma
Status: Enrolling, Phase
Updated: 12/15/2015
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Rocky Mountain Cancer Centers, Site #191
mi
from
Boulder, CO
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
US Oncology - Texas Oncology, PA - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Gettysburg Cancer Center
mi
from
Gettysburg, PA
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
US Oncology - Comprehensive Cancer Center of Nevada, Site #169
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Signal Point Clinical Research Center, LLC
mi
from
Middletown, OH
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
US Oncology - Texas Oncology Midland, Site #173
mi
from
Midland, TX
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Providence Cancer Center Oncology and Hematology Care Eastside, Site #194
mi
from
Portland, OR
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
VCU Massey Cancer Center, Dalton Oncology Clinic, Site #069
mi
from
Richmond, VA
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Duarte, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Jewish Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Freeman Cancer Institute
mi
from
Joplin, MO
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Smilow Cancer Hospital of Yale New Haven
mi
from
New Haven, CT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Division Of Hematology & Oncology Ctr. For Health Sciences
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Nebraska Cancer Specialists
mi
from
Omaha, NE
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Children's National Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Amyloidosis Clinical Trial
Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
Status: Enrolling
Updated: 2/27/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
Status: Enrolling
Updated: 3/8/2013
Texas Childen's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 1/2/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Music Therapy on Nausea and Pain for Autologous Stem Cell
Status: Enrolling
Updated: 12/3/2012
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multidrug Resistance Clinical Trial
Study of the Human Microbiome in Clinical Center Patients
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 … 121